Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Inhibrex Biosciences

Mentioned in 1 analyzed podcast episode across 1 show

Episode Mentions

Pharma and BioTech Daily

Pharma and BioTech Daily · May 13, 2026

Pfizer's $85M Breast Cancer Deal & FDA Shakeup | Pharma and Biotech Daily

Phase 2 trial showed INBRX106 with Pembrolizumab doubled response rates in head and neck squamous cell carcinoma

FDA Leadership Transition and Regulatory StrategyPrecision Oncology and Targeted Breast Cancer TherapiesBiosimilar Competition and Market Erosion
View Analysis